Brief: TherapeuticsMD Inc Appoints Hugh O’Dowd As Chief Executive Officer
Dec 20 (Reuters) - TherapeuticsMD Inc TXMD.O :
* THERAPEUTICSMD INC - ON DEC 14, 2021, BOARD OF CO,
APPOINTED
HUGH O’DOWD, CO’S PRESIDENT, AS CO’S CHIEF EXECUTIVE OFFICER
* THERAPEUTICSMD INC - O’DOWD SUCCEEDS ROBERT FINIZIO AS
CO’S
CHIEF EXECUTIVE OFFICER
* THERAPEUTICSMD INC - FINIZIO WILL CONTINUE TO SERVE AS
VICE
CHAIR OF BOARD
Further company coverage: TXMD.O
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract